Lyme disease is caused by a bacterium, not a parasite. The culprit is Borrelia burgdorferi, a spiral-shaped bacterium transmitted to humans through the bite of infected black-legged ticks.1Lyme Disease. Lyme Disease: Public Education The confusion between “parasite” and “bacteria” is understandable, though, because researchers themselves describe Borrelia as living a parasitic lifestyle, and because tick bites can simultaneously deliver a genuine parasite alongside the bacterium. Untangling the terminology reveals a lot about how this pathogen actually works.
Why the Confusion Exists
In everyday language, “parasite” usually conjures images of worms, ticks, or single-celled organisms like the ones that cause malaria. Biologists, however, use the word more broadly: any organism that depends entirely on a host for survival and reproduction can be called parasitic. Borrelia burgdorferi fits that broader definition. It cannot survive on its own in the environment. It must cycle between tick vectors and mammalian hosts to complete its life cycle, making it what microbiologists call an “obligate parasite.”2PubMed Central. Biology of infection with Borrelia burgdorferi A separate review describes Lyme disease Borrelia as “obligately parasitic, tick-transmitted, invasive, persistent bacterial pathogens” that cause disease primarily through inflammation.3PubMed Central. Lyme Disease Pathogenesis
So when a doctor says Lyme disease is caused by a bacterium and a biologist calls that same organism a parasite, neither is wrong. They are using different classification systems. The medical classification matters most to patients: B. burgdorferi is a bacterium, which means it is treatable with antibiotics. A true eukaryotic parasite, like the one that causes malaria, requires entirely different drugs. Getting the category right determines which treatments work.
What Kind of Bacterium Is It
Borrelia burgdorferi belongs to a group of bacteria called spirochetes, named for their distinctive corkscrew shape. That shape is not just cosmetic. It allows the bacterium to burrow through tissue in ways that most other bacteria cannot. Research using gelatin matrices to mimic living tissue found that B. burgdorferi transitions between at least three different motility states, relying on temporary adhesions to surrounding material, and can push through pores much smaller than its own diameter.4PubMed Central. The heterogeneous motility of the Lyme disease spirochete in gelatin mimics dissemination through tissue This drilling ability helps the spirochete spread from the initial tick bite into joints, the nervous system, and the heart.
The spirochete family includes a few other notorious human pathogens. The syphilis bacterium, Treponema pallidum, is a close relative. Genome comparisons show that the two share less than half of their genes in clearly recognizable form, reflecting a long evolutionary separation driven by their adaptation to very different biological niches.5PubMed Central. Comparative genome analysis of the pathogenic spirochetes Borrelia burgdorferi and Treponema pallidum What they do share, though, is a strategy of persistence: both use rare, poorly recognized surface proteins to avoid the immune system and can linger in a host for long periods if untreated.6Trends in Microbiology. Comparative architecture of Treponema pallidum and Borrelia burgdorferi Their most abundant membrane proteins carry covalently attached fatty acids, with palmitate as the predominant one in both species.7PubMed Central. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins
A Costume Change Between Hosts
One of the more remarkable things about B. burgdorferi is how aggressively it remodels itself depending on where it is. Inside a tick’s gut, the spirochete wears one set of surface proteins. When the tick begins feeding on a mammal, the bacterium detects the change in temperature and other cues and rapidly swaps those proteins for a different set tailored to surviving in mammalian tissue. This environmentally responsive protein switching is considered a hallmark of Borrelia‘s infectious cycle.8PubMed Central. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals
The protein called OspC, for instance, is produced in the tick during its blood meal and then dialed down after the spirochete has entered the mammalian host. Researchers who created a B. burgdorferi mutant lacking OspC found that the mutant could not establish infection in mammals, confirming that OspC is essential for the transition between tick and host. Meanwhile, a separate family of surface proteins called CRASPs (complement regulator-acquiring surface proteins) each show distinct expression patterns at different stages of the tick-mammal cycle, reflecting how finely tuned this costume change really is.9PubMed Central. Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle
Beyond swapping surface proteins, B. burgdorferi can form dormant subpopulations when conditions become hostile. Changes in temperature, acidity, nutrient content, and other stressors trigger shifts in gene expression that produce “persister” cells, a dormant state that can withstand conditions that would kill actively growing spirochetes.10PubMed Central. Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters This ability to hunker down is part of why Lyme disease can be so tricky to fully resolve in some patients.
How the Tick Helps the Bacterium
The tick is not just a passive shuttle. Its saliva is a cocktail of biologically active compounds with anti-inflammatory, immunosuppressive, anticoagulant, and vasodilatory properties, all of which keep the host from noticing the bite and mounting an effective early immune response.11PubMed Central. The Essential Role of Tick Salivary Glands and Saliva in Tick Feeding and Pathogen Transmission Borrelia spirochetes have coevolved with ticks to exploit this chemical cover. Research on a tick salivary protein from Ixodes persulcatus showed that it directly interacts with a key immune receptor (LTβR) to block downstream immune signaling, suppressing the host’s defenses at the bite site and facilitating spirochete transmission.12PubMed Central. Interference with LTβR signaling by tick saliva facilitates transmission of Lyme disease spirochetes
This partnership between pathogen and vector is a reason why the standard advice about prompt tick removal matters so much. The longer a tick feeds, the more saliva it injects and the more time spirochetes have to migrate from the tick’s gut into the host’s skin.
Evading the Immune System Once Inside
After the spirochete enters mammalian tissue, it faces a new challenge: the adaptive immune system. B. burgdorferi has an unusually diverse toolkit for dodging immune detection. It manipulates surface protein expression (as discussed above), co-opts tick saliva effects that persist at the bite wound, resists antimicrobial peptides that the host deploys as a first line of defense, and can even disable germinal centers, the immune structures where the body normally mounts targeted antibody responses.13PubMed Central. The Brilliance of Borrelia: Mechanisms of Host Immune Evasion by Lyme Disease-Causing Spirochetes
This evasion capacity is part of what makes the “parasite” label feel intuitive to many people. The bacterium behaves like a skilled infiltrator, changing disguises, suppressing alarms, and establishing long-term residence if not cleared by antibiotics. Few other bacteria demonstrate this level of host manipulation, which is more typically associated with protozoan parasites or viruses.
When an Actual Parasite Comes Along for the Ride
Here is where the parasite question gets a practical twist. The same ticks that carry B. burgdorferi often carry other pathogens, including a genuine parasite: Babesia microti, a protozoan that infects red blood cells and causes babesiosis. Studies indicate that coinfection with both B. burgdorferi and B. microti is more common than you would expect if the two pathogens were distributed independently. One large field study found coinfection rates about 83% higher than predicted by chance.14PLOS ONE. Co-Infection of Blacklegged Ticks with Babesia microti and Borrelia burgdorferi Is Higher than Expected and Acquired from Small Mammal Hosts The same ticks also transmit Anaplasma phagocytophilum, another bacterium that causes human granulocytic anaplasmosis.15Clinical Infectious Diseases. Lyme Disease and Human Granulocytic Anaplasmosis Coinfection: Impact of Case Definition on Coinfection Rates and Illness Severity
Research on the ecological dynamics of these coinfections suggests that B. burgdorferi and B. microti together promote each other’s transmission and emergence, and that coinfection causes more severe and longer-lasting illness in humans than either pathogen alone.16PubMed Central. Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences So while Lyme disease itself is bacterial, a single tick bite can deliver a bacterial infection and a parasitic one simultaneously. A person who has been told they have “a parasite from a tick bite” may actually be hearing about babesiosis, not Lyme disease, or they may have both.
How Lyme Disease Is Diagnosed
Diagnosis relies primarily on antibody-based blood tests rather than direct detection of the bacterium. The standard approach is a two-tiered system: a screening test (an enzyme immunoassay) followed by a confirmatory Western blot if the screen is positive or borderline.17PubMed Central. Laboratory diagnostics for Lyme disease An alternative second-tier option uses a peptide-based test (the C6 peptide ELISA) instead of the Western blot.18Clinical Infectious Diseases. Prospective Study of Serologic Tests for Lyme Disease
The fact that diagnosis is indirect, measuring the immune response to the bacterium rather than the bacterium itself, creates frustration for many patients. Antibodies take time to develop, so tests in the first few weeks after a bite may come back negative even if the person is infected. This window of seronegativity is one reason clinicians are advised to treat early Lyme disease based on clinical signs (especially the classic bull’s-eye rash) without waiting for lab confirmation. It also fuels a long-running controversy about whether standard tests miss chronic infections, which has spawned an alternative diagnostic market of non-validated tests.19PLoS ONE. The social representations of diagnosing Lyme disease
Post-Treatment Symptoms and Why They Linger
Most people treated with a standard course of antibiotics recover fully. But a subset, often estimated at around 10 to 20 percent, continue to experience fatigue, pain, and cognitive difficulties for months or longer after treatment. This condition is now generally called post-treatment Lyme disease syndrome (PTLDS). The question of whether lingering symptoms mean the bacterium is still alive or whether the immune system has gone haywire on its own is one of the most contentious debates in infectious disease.
Research on a specific manifestation, antibiotic-refractory Lyme arthritis, offers some clues. Even after spirochetes are cleared, bacterial cell-wall fragments (peptidoglycan) can persist in joint fluid and may continue to drive an inflammatory response. On top of that, the excessive inflammation appears to cause vascular damage and tissue injury that leads the immune system to start reacting to the body’s own proteins, creating autoimmune-like responses involving antibodies against components such as endothelial cell growth factor and certain structural proteins.20JCI Insight. Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses In other words, the bacterium may be gone, but the damage it caused keeps the immune system firing.
This is another area where the “parasite vs. bacteria” confusion has real consequences. Some patients, particularly those who seek out alternative practitioners, receive prolonged courses of antiparasitic drugs alongside or instead of antibiotics, based on the idea that Lyme is caused by or accompanied by a parasite. For actual Babesia coinfection, antiparasitic treatment is appropriate. But for Lyme disease itself, antibiotics are the evidence-based treatment, because the pathogen is a bacterium.
The Mice Behind the Disease
Understanding Lyme disease requires understanding the animals that silently maintain the bacterium in nature. In the United States, white-footed mice (Peromyscus leucopus) are the primary reservoir. These mice tolerate the spirochete without getting visibly sick, serving as a reliable source from which new ticks pick up the infection and later pass it to humans.21PubMed Central. Do white-footed mice, the main reservoir of the Lyme disease pathogen in the United States, clinically respond to the borrelial tenancy? When researchers experimentally infected white-footed mice with the related species Borrelia mayonii via tick bites, over 90% of the mice became infected, and roughly three-quarters of larval ticks that subsequently fed on those mice acquired the spirochete.22PubMed Central. Experimental Demonstration of Reservoir Competence of the White-Footed Mouse, Peromyscus leucopus, for the Lyme Disease Spirochete, Borrelia mayonii
This efficiency has led researchers to try an unconventional prevention strategy: vaccinating the mice instead of the humans. In a field experiment, wild white-footed mice were immunized with a recombinant version of the spirochete’s outer surface protein A (OspA). The following year, the prevalence of B. burgdorferi in ticks collected from those sites dropped significantly compared to control sites.23PubMed Central. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle The idea is elegant: break the cycle in the reservoir animal, and fewer infected ticks ever reach humans. Products based on this concept have been tested in bait-box delivery systems placed in areas with high tick density.
How the Discovery Happened
Lyme disease was recognized as a distinct condition in the mid-1970s after a cluster of juvenile arthritis cases near Lyme, Connecticut, but the cause remained mysterious for years. Researchers initially considered viruses, toxins, and various other agents. The breakthrough came in 1982 when Willy Burgdorfer, examining tick gut tissue under a microscope, spotted spirochete bacteria inside Ixodes dammini ticks collected from endemic areas.24PubMed. Lyme disease-a tick-borne spirochetosis? The organism was subsequently named Borrelia burgdorferi in his honor. A later historical review traced the various competing hypotheses about the cause of both European erythema migrans (the bull’s-eye rash) and the American Lyme disease cluster, showing how the discovery unified what had seemed like separate conditions under a single spirochetal cause.25PubMed Central. Discovery of the Lyme disease spirochete and its relation to tick vectors
Since then, researchers have identified multiple species within the Borrelia burgdorferi sensu lato complex. In Europe, B. afzelii and B. garinii cause the majority of Lyme disease, and different species tend to produce different clinical patterns. Molecular typing methods have revealed substantial genetic diversity among these species, with genetic diversity values at individual loci ranging widely across globally diverse isolates.26PubMed Central. Strain typing of Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii by using multiple-locus variable-number tandem repeat analysis Earlier work using enzyme electrophoresis across European isolates found links between specific Borrelia species and particular clinical manifestations, suggesting that the type of Lyme disease you get may depend partly on which species infects you.27Research in Microbiology. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato In Europe, B. garinii is more often linked to neurological symptoms, while B. afzelii tends to cause skin-related disease. In North America, B. burgdorferi sensu stricto predominates and is associated with arthritis more frequently than the European species are.
That strain-level variation matters for diagnosis, treatment, and vaccine development, and it underscores that “Lyme disease” is not one monolithic infection. It is a family of closely related bacterial infections, each with its own tendencies, all carried by ticks, and none of them caused by a parasite.